Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.zenlabsethica.com | |
Market Cap | 30.27 Cr. | |
Enterprise Value(EV) | 31.25 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.61 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 28.80 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 67.35 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 15.36 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 3.03 | Calculated using Price: 46.50 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.65 Cr. | 6,510,015 Shares |
FaceValue | 10 | |
Company Profile | ||
Zenlabs Ethica is one of the leading marketing companies and in collaboration with Zenlabs Pharmaceutical Inc, Canada, the company develops and markets a wide range of quality, affordable and branded drugs. |
1 Day |
|
+3.87% |
1 Week |
|
-1.83% |
1 Month |
|
-3.78% |
3 Month |
|
-38.63% |
6 Month |
|
+6.15% |
1 Year |
|
+36.06% |
2 Year |
|
+57.84% |
5 Year |
|
-12.48% |
10 Year |
|
+468.24% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -2.72 | -3.31 | 5.04 | 17.99 | 18.18 | 16.53 | -11.05 | 9.61 | 9.17 | |
Return on Capital Employed (%) | -2.72 | -3.00 | 2.90 | 21.03 | 23.85 | 23.44 | -11.27 | 13.77 | 16.59 | |
Return on Assets (%) | -1.47 | -1.76 | 1.00 | 2.99 | 3.69 | 3.91 | -2.53 | 2.35 | 2.37 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 2 | 2 | 5 | 6 | 7 | 8 | 7 | 9 | 9 | 10 | |
Non Curr. Liab. | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 2 | 2 | 4 | |
Curr. Liab. | 2 | 2 | 25 | 27 | 22 | 26 | 26 | 21 | 26 | 28 | |
Minority Int. | |||||||||||
Equity & Liab. | 4 | 4 | 30 | 33 | 30 | 35 | 34 | 32 | 38 | 42 | |
Non Curr. Assets | 0 | 3 | 3 | 3 | 2 | 2 | 2 | 4 | 4 | 6 | |
Curr. Assets | 4 | 1 | 27 | 31 | 28 | 33 | 32 | 27 | 33 | 36 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4 | 4 | 30 | 33 | 30 | 35 | 34 | 32 | 38 | 42 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 16 | 81 | 72 | 67 | 60 | 57 | 69 | 67 | |||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Total Income | 16 | 81 | 72 | 67 | 60 | 57 | 69 | 67 | |||
Total Expenditure | 0 | 0 | -16 | -80 | -70 | -65 | -61 | -55 | -67 | -64 | |
PBIDT | 0 | 0 | 0 | 2 | 2 | 2 | -1 | 2 | 3 | 3 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | ||
Exceptional Items | 0 | ||||||||||
PAT | 0 | 0 | 0 | 1 | 1 | 1 | -1 | 1 | 1 | 1 | |
Adjusted EPS | 0 | 0 | 0 | 1 | 2 | 2 | -1 | 1 | 1 | 2 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 1 | -1 | 0 | 1 | 0 | -8 | 0 | ||
Cash Fr. Inv. | -2 | 0 | 0 | 0 | 0 | 0 | |||||
Cash Fr. Finan. | 3 | 0 | 0 | 0 | 0 | -1 | 0 | ||||
Net Change | 0 | 0 | 2 | -1 | 0 | 0 | 0 | -9 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 2 | 1 | 1 | 2 | 2 | 2 | 2 |
Thu, 19 Jan 2023
Clarification sought from Zenlabs Ethica Ltd The Exchange has sought clarification from Zenlabs Ethica Ltd on January 18 2023 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited. |
Thu, 19 Jan 2023
Clarification On Price Movement Clarification on Price Movement |
Thu, 05 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance-Certifiacte under Reg. 74(5) of SEBI (DP) Regulations 2018 |
Mon, 30 Jan 2023 |
|
|
|
|
|